共 14 条
Complete Response of Advanced Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Sorafenib: A Case Report
被引:33
作者:
Inuzuka, Tadashi
[1
]
Nishikawa, Hiroki
Sekikawa, Akira
Takeda, Haruhiko
Henmi, Shinichiro
Sakamoto, Azusa
Saito, Sumio
Kita, Ryuichi
Kimura, Toru
Osaki, Yukio
Kudo, Masatoshi
[2
]
机构:
[1] Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Tennouji Ku, Osaka 5438555, Japan
[2] Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka 589, Japan
来源:
关键词:
Hepatocellular carcinoma;
Sorafenib;
Hepatic necrosis;
Lung metastasis;
Complete response;
COMPLETE REMISSION;
SYSTEMIC THERAPY;
CANCER;
D O I:
10.1159/000333279
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Sorafenib, an oral multikinase inhibitor, has demonstrated clinical efficacy in patients with advanced hepatocellular carcinoma (HCC). However, in the SHARP trial (Sorafenib HCC Assessment Randomized Protocol trial) and the Asia-Pacific trial (conducted in the Asia-Pacific region), no cases of complete response (CR) were reported. Thereafter, only a relatively small number of CR cases were reported worldwide for sorafenib therapy. We herein report a case of CR in a patient treated with sorafenib for 4 months. The patient had advanced HCC with multiple lung metastases, and there has been no recurrence after 8 months following cessation of administration. To our knowledge, this is the first time a female treated with sorafenib alone for HCC has had a CR. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:152 / 157
页数:6
相关论文